Vanessa F Bonazzi Selected Research

Vanessa F Bonazzi Research Topics

Disease

13	Melanoma (Melanoma, Malignant) 10/2023 - 01/2009
9	Neoplasms (Cancer) 10/2023 - 06/2009
3	Adenocarcinoma 07/2023 - 01/2023
1	Pancreatic Neoplasms (Pancreatic Cancer) 07/2023
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2019
1	Endometrial Neoplasms (Endometrial Cancer) 01/2017

Drug/Important Bio-Agent (IBA)

4	Biomarkers (Surrogate Marker)IBA 10/2023 - 01/2021
4	MicroRNAs (MicroRNA)IBA 08/2016 - 06/2011
2	Proteins (Proteins, Gene)FDA Link 01/2021 - 12/2011
2	Messenger RNA (mRNA)IBA 08/2017 - 01/2009
1	ErbB Receptors (EGF Receptor)IBA 10/2023
1	Circulating Tumor DNAIBA 10/2023
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 10/2023
1	Cyclin-Dependent Kinase 4IBA 10/2023
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 10/2023
1	TOR Serine-Threonine KinasesIBA 10/2023
1	Albumin-Bound Paclitaxel FDA Link 07/2023
1	C-Reactive ProteinIBA 07/2023
1	Gemcitabine FDA Link 07/2023
1	TetraspaninsIBA 01/2021
1	CaspasesIBA 01/2019
1	benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketoneIBA 01/2019
1	Type 2 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 2)IBA 01/2019
1	2- (1H- indazol- 4- yl)- 6- (4- methanesulfonylpiperazin- 1- ylmethyl)- 4- morpholin- 4- ylthieno(3,2- d)pyrimidineIBA 01/2017
1	AlpelisibIBA 01/2017
1	infigratinibIBA 01/2017
1	Biotin (Vitamin H)FDA Link 08/2016
1	LuciferasesIBA 07/2015
1	VemurafenibIBA 07/2015
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 04/2012
1	MAP Kinase Kinase Kinases (MAP Kinase Kinase Kinase)IBA 12/2011
1	Temozolomide (Temodar)FDA LinkGeneric 12/2011
1	Small Interfering RNA (siRNA)IBA 12/2011
1	MitogensIBA 12/2011
1	Transcription Factors (Transcription Factor)IBA 06/2011
1	alpha2 Subunit Collagen Type IIBA 01/2011
1	Cadherins (E-Cadherin)IBA 06/2009
1	H-cadherin (T-cadherin)IBA 06/2009
1	trichostatin A (A 300)IBA 01/2009
1	Decitabine FDA Link 01/2009
1	Histone Deacetylases (Histone Deacetylase)IBA 01/2009

Therapy/Procedure

2	Drug Therapy (Chemotherapy) 01/2023 - 12/2013
2	Neoadjuvant Therapy 01/2023 - 01/2023
2	Therapeutics 10/2020 - 01/2017
1	Immunotherapy 01/2021